Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    18539917 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
Condition: Heart Failure
Interventions: Drug: inactivated trivalent influenza vaccine;   Other: Sterile saline
2 Completed FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Condition: Type 2 Diabetes
Interventions: Drug: "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)];   Drug: Insulin glargine, metformin, prandial insulin
3 Not yet recruiting Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes
Condition: Diabetes Mellitus, Type II
Interventions: Drug: triple combination therapy;   Drug: Stepwise add-on therapy
4 Not yet recruiting HbA1c Variability in Type II Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Metformin;   Drug: Gliclazide;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Pioglitazone;   Drug: Dapagliflozin;   Drug: human insulin
5 Recruiting Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
Conditions: Heart Failure;   Influenza
Interventions: Other: Sterile saline;   Drug: inactivated trivalent influenza vaccine
6 Active, not recruiting Dietary Intervention in Type-2 Diabetes and Pre-Diabetes
Conditions: Diabetes Mellitus, Type 2;   Pre-diabetes;   Metabolic Syndrome
Intervention: Other: Virta Program
7 Unknown  Carotid Atherosclerosis In Newly Diagnosed Type 2 Individuals
Condition: Type II Diabetes Mellitus Without Mention of Complication
Intervention: Other: Standard care
8 Completed Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients
Condition: Diabetes Mellitus
Intervention: Drug: Basal-bolus detemir-aspart insulin regimen
9 Withdrawn A Comparison of Strict Glucose Control With Usual Care at the Time of Islet Cell Transplantation
Conditions: Diabetes Mellitus, Type 1;   Islet Transplantation
Intervention: Other: Strict glucose control
10 Completed
Has Results
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Conditions: Atherosclerosis;   Cardiovascular Diseases;   Hypercholesterolemia;   Hypertension;   Diabetes Mellitus, Type 2;   Diabetes Mellitus;   Coronary Disease
Interventions: Drug: Anti-hyperglycemic Agents;   Drug: Anti-hypertensive Agents;   Drug: Blinded fenofibrate or placebo plus simvastatin

Study has passed its completion date and status has not been verified in more than two years.